Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Front-line consolidation with CAR-t therapy in newly diagnosed adult ph-negative b-acute lymphoblastic leukemia: Results from a prospective, phase 2 study

View Full Paper
Ask AI
Bookmark
Share

Authors

XGXiaoyuan GongQFQiuyun FangDLDong Lin

Discussion

Loading...

Member takes

Overview

Prospective trial shows CAR-T consolidation improves outcomes in newly diagnosed Ph-negative B-ALL, indicating a safer treatment model.

Key Points

  • CAR-T therapy achieved significant cancer eradication and favorable safety without severe toxicity.
  • In 44 participants, the intervention resulted in a 100% overall survival rate within 1 year of treatment.
  • Assessment focused on the effects of CAR-T consolidation after standard therapy, enhancing patient prognosis.
  • Results suggest CAR-T consolidation may replace traditional therapies, minimizing adverse effects overall.

Cite This Study

Gong et al. (2025) studied this question.

synapsesocial.com/papers/69362f634fa91c937236de6chttps://doi.org/10.1182/blood-2025-1561
View Full Paper
Ask AI
Bookmark
Share